期刊文献+

以间质性肺疾病起病的皮肌炎临床特点分析 被引量:10

Interstitial lung disease as an initial manifestation of dermatomyositis
原文传递
导出
摘要 目的 探讨以间质性肺疾病(ILD)起病的皮肌炎患者的临床特点和预后.方法 北京协和医院1999年1月至2013年1月皮肌炎并ILD住院患者资料完整者共184例,回顾性分析其临床表现、生化指标、抗体谱、影像学、肺功能、肺活体组织检查学、治疗及转归等,并对ILD起病组及非ILD起病组皮肌炎患者进行上述指标的比较.结果 皮肌炎住院患者并发ILD的发生率为17%,平均年龄(48±12)岁,男∶女=63∶121.ILD起病组88例(47.8%),包括ILD与皮肌炎同时发生(1个月内)42例(22.8%),以及ILD先于皮肌炎发生46例(25.0%),后者ILD平均先于皮肌炎(11±3)个月发生.ILD起病组活动后气短、咳嗽和肺部爆裂音的发生率高于非ILD起病组,而向阳疹、前胸Ⅴ区皮疹、披肩征和关节受累的发生率较后者低(P<0.05).ILD起病组与非ILD起病组相比,肌酶水平、抗核抗体和抗SSA阳性率更低(P<0.05),抗Jo-1抗体阳性率(13.6%)差异无统计学意义(P>0.05).ILD起病的皮肌炎主要表现为弥散功能及限制性通气功能障碍,一氧化碳弥散率显著低于非ILD起病组(P<0.01).ILD起病的皮肌炎临床病理类型主要是机化性肺炎和非特异性间质性肺炎.ILD起病组病死率19.3%,两组差异无统计学意义(P>0.05).死亡原因主要是ILD进展所致呼吸衰竭(13例,76.5%).结论 以ILD起病的皮肌炎临床常见,是皮肌炎住院患者主要死亡原因.其主要临床病理类型是机化性肺炎和非特异性间质性肺炎. Objective To explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ILD) as an initial manifestation.Methods Medical records of 184 dermatomyositis inpatients complicated with ILD,admitted into Peking Union Medical College Hospital from January 1999 to January 2013,were retrospectively analyzed.The clinical features,biochemical parameters,positive rates of autoantibodies,radiology,pulmonary function tests,pathology,treatments and prognosis were compared between two subgroups of ILD-initial and non-ILD-initial dermatomyositis.Results The incidence of ILD of dermatomyositis inpatients was 17%.The average age was 48 ± 12 years and the gender ratio of male-to-female was 63∶ 121.Eighty eight (47.8%) dermatomyositis patients had ILD as an initial manifestation,including (n =42,22.8%) of ILD concomitant dermatomyositis (within 1 month) and (n =46,25.0%) of ILD before dermatomyositis with an average ahead time of (11 ± 3) months.Patients of ILD-initial dermatomyositis had a higher incidence of dyspnea on exertion,cough and lung crackles,but there were lower incidences of heliotrope rash,chest Ⅴ area rash,shawl sign and joint involvement than non-ILD-initial dermatomyositis (P < 0.05).The positive rate of anti-Jo-1 antibodies of ILD-initial dermatomyositis group was 13.6%.The main performances of ILD-initial dermatomyositis on pulmonary function tests were diffusing and restrictive ventilation impairment.And there was a lower diffusing rate of carbon monoxide than non-ILD-initial dermatomyositis group (P < 0.01).Organic and non-specific interstitial pneumonias were the major clinical pathology types of ILD-initial dermatomyositis.The mortality rate of ILD-initial dermatomyositis patients was 19.3% and there was no significant difference from non-ILD-initial dermatomyositis (P > 0.05).The main course of ILD-initial dermatomyositis was respiratory failure due to progressive ILD (n =13,76.5%).Conclusions ILD as an initial manifestation is a common complication and a major mortality cause of dermatomyositis inpatients.And the frequent clinical pathology types are organic and non-specific interstitial pneumonias.Symptoms of skin and muscle,creatine kinase and anti-synthetase antibodies should be closely monitored.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第43期3402-3406,共5页 National Medical Journal of China
基金 中华医学会临床医学科研专项基金(12040760376)
关键词 皮肌炎 肺疾病 间质性 抗体 Dermatomyositis Interstitial lung disease Antinuclear antibody Jo 1
  • 相关文献

参考文献11

  • 1Fathi M, Lundberg IE. Interstitial lung disease in polymyositisand dermatomyositis [ J ]. CUlT Opin Rheumatol, 2005, 17:701 706.
  • 2Cottin V, Thivolet-B6jui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis [ J ]. Eur Respir J, 2003, 22 : 245 -250.
  • 3Chen IJ, Jan Wu IJ, Lin CW, et al. Interstitial lung disease in polymyositis and dermatomyositis [ J ]. Clin Rheumatol, 2009, 28 : 639-646.
  • 4Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis [J]. Ann Rheum Dis, 2004, 63: 297-301.
  • 5Marie I, Hatron PY, Dominique S, et al. Short-term and long- term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients [ J]. Arthritis Rheum, 2011, 63 : 3439-3447.
  • 6Bohan A, Peter JB. Polymyositis and dermatomyositis ( first of two parts) [J]. N Engl J Med, 1975, 292: 344-347.
  • 7Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin6 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? [ J ]. J Am Acad Dermatol, 2002,46:626-636.
  • 8Marie I, Josse S, Hatron PY, et al. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome [ J 1. Arthritis Care Res, 2013, 65:800-808.
  • 9Connors GR, Christopher-Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? [ J]. Chest, 2010, 138:1464-1474.
  • 10张卓莉,赖爱云,徐东,陈益和,唐福林.临床无肌病皮肌炎29例临床分析[J].中华医学杂志,2007,87(19):1345-1347. 被引量:14

二级参考文献9

  • 1张清安,李中学,向兰兰,黄娟.皮肌炎与多发性肌炎73例临床分析[J].中国实用内科杂志,2005,25(4):354-355. 被引量:4
  • 2Sontherimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol, 2002,46:626-636.
  • 3Dawkins MA, Jorizzo JL, Walker FO, et al. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol, 1998,38: 397-404.
  • 4Caproni M, Cardinali C, Parodi A, et al. Amyopathic dermatomyositis : a review by the Italian Group of Immunodermatology. Arch Dermatol, 2002,138:23-27.
  • 5Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis- dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med, 2001,164 : 1182-1185.
  • 6Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/dermatomyositis : an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum, 1986,15 : 168-178.
  • 7Neuhaus IM, Connolly MK. An unusual presentation of amyopathic dermatomyositis associated with fatal interstitial lung disease. Arch Dermatol, 2006,142 : 113-114.
  • 8Sakamoto N, Mukae H, Fujii T, et al. Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis. Intern Med, 2004, 43:838-842.
  • 9Gerami P, Schope JM, McDonald L, et al. A systemic review ot adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis ): missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol, 2006, 54 : 597-631.

共引文献13

同被引文献177

  • 1林辉,梁燕,王英,岑筱敏,尹耕,谢其冰.典型皮肌炎或临床无肌炎皮肌炎并发间质性肺病的临床特点和危险因素分析[J].四川大学学报(医学版),2013,44(5):805-809. 被引量:6
  • 2李晓红,舒健翔,王宏伟.儿童风湿性疾病的肺部表现[J].国外医学(儿科学分册),2003,30(6):333-335. 被引量:6
  • 3徐作军.多发性肌炎/皮肌炎的肺损害[J].中华结核和呼吸杂志,2007,30(4):245-247. 被引量:9
  • 4徐凌,沈策.机化性肺炎的研究进展[J].国际呼吸杂志,2007,27(24):1903-1906. 被引量:7
  • 5Bohan A,Peter JB.Polymyositis and dermatomyositis(first of two parts)[J].N Engl Med,1975,292(7):344-347.
  • 6Raghu G,Collard HR,Egan JJ,et al.An official ATS/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidencebased guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183(6):788-824.
  • 7Mimori T,Nakashima R,Hosono Y.Interstitial lung disease in myositis:clinical subsets,biomarkers,and treatment[J].Curr Rheumatol Rep,2012,14(3):264-274.
  • 8Selva-O′callaghan A,Labrador-Horrillo M,Muoz-Gall X,et al.Polymyositis/dermatomyositis-associated lung disease:analysis of a series of 81patients[J].Lupus,2005,14(7):534-542.
  • 9Demedts M,Costabel U.ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias[J].Eur Respir J,2002,19(5):794-796.
  • 10Tanizawa K,Handa T,Nakashima R,et al.The prognostic value of HRCT in myositis-associated interstitial lung disease[J].Respir Med,2013,107(5):745-752.

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部